Charles Schwab’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.12M Sell
450,207
-25,658
-5% -$121K ﹤0.01% 2648
2025
Q1
$2.18M Sell
475,865
-82,581
-15% -$379K ﹤0.01% 2584
2024
Q4
$2.67M Sell
558,446
-37,764
-6% -$181K ﹤0.01% 2589
2024
Q3
$2.8M Buy
596,210
+3,473
+0.6% +$16.3K ﹤0.01% 2604
2024
Q2
$3.35M Sell
592,737
-75,443
-11% -$426K ﹤0.01% 2526
2024
Q1
$2.75M Buy
668,180
+23,051
+4% +$94.7K ﹤0.01% 2506
2023
Q4
$2.72M Sell
645,129
-1,119
-0.2% -$4.72K ﹤0.01% 2522
2023
Q3
$2.79M Buy
646,248
+8,176
+1% +$35.3K ﹤0.01% 2499
2023
Q2
$4.2M Buy
638,072
+5,715
+0.9% +$37.7K ﹤0.01% 2301
2023
Q1
$4.29M Sell
632,357
-32,678
-5% -$222K ﹤0.01% 2278
2022
Q4
$4.91M Buy
665,035
+20,179
+3% +$149K ﹤0.01% 2218
2022
Q3
$6.37M Buy
644,856
+10,378
+2% +$103K ﹤0.01% 2092
2022
Q2
$6.92M Sell
634,478
-44,904
-7% -$489K ﹤0.01% 2023
2022
Q1
$7.68M Sell
679,382
-27,910
-4% -$316K ﹤0.01% 2080
2021
Q4
$11.1M Buy
707,292
+67,410
+11% +$1.06M ﹤0.01% 1946
2021
Q3
$11M Buy
639,882
+84,975
+15% +$1.46M ﹤0.01% 1952
2021
Q2
$11.9M Buy
554,907
+144,050
+35% +$3.1M ﹤0.01% 1909
2021
Q1
$6.17M Buy
410,857
+54,575
+15% +$820K ﹤0.01% 2190
2020
Q4
$4.68M Buy
356,282
+1,731
+0.5% +$22.7K ﹤0.01% 2249
2020
Q3
$3.43M Sell
354,551
-923
-0.3% -$8.92K ﹤0.01% 2255
2020
Q2
$4.07M Buy
355,474
+26,973
+8% +$309K ﹤0.01% 2121
2020
Q1
$3.4M Sell
328,501
-95,974
-23% -$995K ﹤0.01% 2030
2019
Q4
$6.97M Sell
424,475
-104,103
-20% -$1.71M ﹤0.01% 1848
2019
Q3
$7.02M Buy
528,578
+73,819
+16% +$980K ﹤0.01% 1803
2019
Q2
$6.41M Buy
454,759
+18,447
+4% +$260K ﹤0.01% 1850
2019
Q1
$8.03M Buy
436,312
+72,121
+20% +$1.33M 0.01% 1726
2018
Q4
$9.52M Sell
364,191
-43,027
-11% -$1.12M 0.01% 1492
2018
Q3
$9.35M Buy
407,218
+15,279
+4% +$351K 0.01% 1682
2018
Q2
$7.47M Buy
391,939
+9,802
+3% +$187K 0.01% 1779
2018
Q1
$6.44M Sell
382,137
-99,875
-21% -$1.68M 0.01% 1797
2017
Q4
$7.33M Buy
482,012
+9,496
+2% +$144K 0.01% 1689
2017
Q3
$8.46M Buy
472,516
+11,647
+3% +$209K 0.01% 1542
2017
Q2
$7.51M Buy
460,869
+16,183
+4% +$264K 0.01% 1544
2017
Q1
$6.23M Buy
444,686
+10,383
+2% +$145K 0.01% 1629
2016
Q4
$6.93M Buy
434,303
+38,338
+10% +$612K 0.01% 1523
2016
Q3
$6.59M Buy
395,965
+82,877
+26% +$1.38M 0.01% 1461
2016
Q2
$3.5M Buy
313,088
+12,909
+4% +$144K ﹤0.01% 1780
2016
Q1
$2.51M Buy
300,179
+31,546
+12% +$264K ﹤0.01% 1928
2015
Q4
$2.5M Buy
268,633
+194,080
+260% +$1.81M ﹤0.01% 1956
2015
Q3
$841K Hold
74,553
﹤0.01% 2441
2015
Q2
$947K Hold
74,553
﹤0.01% 2437
2015
Q1
$694K Buy
74,553
+13,300
+22% +$124K ﹤0.01% 2519
2014
Q4
$878K Hold
61,253
﹤0.01% 2414
2014
Q3
$636K Buy
61,253
+13,953
+29% +$145K ﹤0.01% 2500
2014
Q2
$766K Hold
47,300
﹤0.01% 2444
2014
Q1
$769K Hold
47,300
﹤0.01% 2408
2013
Q4
$587K Hold
47,300
﹤0.01% 2531
2013
Q3
$521K Buy
47,300
+9,700
+26% +$107K ﹤0.01% 2533
2013
Q2
$316K Buy
+37,600
New +$316K ﹤0.01% 2710